Format

Send to

Choose Destination
Clin Rev Allergy Immunol. 2018 Oct;55(2):237. doi: 10.1007/s12016-018-8704-1.

Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies.

Author information

1
Division of Rheumatology, University of Padova, Via Giustiniani, 2, 35128, Padova, Italy.
2
Division of Rheumatology, University of Padova, Via Giustiniani, 2, 35128, Padova, Italy. adoria@unipd.it.

Abstract

The following changes are made for this article: (1.) Maddalena Larosa's given name and surname were inadvertently interchanged. The authorgroup section is now corrected. (2.) The author(s)' decision to opt for Open Choice.

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center